Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom. Its lead development candidate, ivonescimab, is a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis; and is also in Phase III clinical trials for the treatment of non-small lung cancer. The company has a collaboration and license agreement with Akeso, Inc. and its affiliates to develop and commercialize ivonescimab. Summit Therapeutics Inc. was founded in 2003 and is headquartered in Miami, Florida.

Summit Therapeutics Inc.

Summit Therapeutics stock rallied on Thursday alongside clinical trial results from its partner, Akeso.


Summit Therapeutics Stock (SMMT) Rallies on Positive Clinical Trial Results

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Summit Therapeutics (SMMT), Definitive Healthcare Co...

Analysts Are Bullish on Top Healthcare Stocks: Summit Therapeutics (SMMT), Definitive Healthcare Corp (DH)

Summit Therapeutics ( ($SMMT) ) has issued an announcement. Summit Therapeutics highlighted on September 2, 2026 that partner Akeso’s Phase III HAR...

Summit Therapeutics strengthened by positive ivonescimab survival results

Analysts are intrested in these 5 stocks: ( ($DT) ), ( ($FLNC) ), ( ($FIVE) ), ( ($SMMT) ) and ( ($BNS) ). Here is a breakdown of their recent


Dynatrace, Fluence, Five Below, Summit, BNS Trending With Analysts

The latest announcement is out from Summit Therapeutics ( ($SMMT) ). On August 25, 2026, Summit Therapeutics highlighted positive topline results r...

Summit Therapeutics’ Ivonescimab Shows Phase III Survival Benefit

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Tango Therapeutics (TNGX), Rein Therapeutics (RNTX) ...

Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Rein Therapeutics (RNTX) and Summit Therapeutics (SMMT)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Summit Therapeutics (SMMT) and Alcon (ALC). Summit Therapeutics (...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	SMMT	$17.13	+17.33%	14.88M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	SMMT	$17.13	+17.3%	14.88M
3
4
5
6

SMMT

Get Summit Therapeutics Inc. Data in Excel

Get Summit Therapeutics Inc. Data in Excel